project id: TCGA-HNSC; case submitter id: TCGA-BB-A5HZ; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 8.8; age at index: 65; days to birth: -23906; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 23906; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IVA; ajcc clinical t: T4; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 827.0; icd 10 code: C06.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Mouth, NOS; synchronous malignancy: No; tissue or organ of origin: Mouth, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 213; days to sample procurement: 0; initial weight: 210.0; portion submitter id: TCGA-BB-A5HZ-01A-21; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 20.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0;